Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).

× No keyword cloud information.

26 in total

Review 1. Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors: Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal: Pharm Res Date: 2013-06-26 Impact factor: 4.200

2. VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancer.

Authors: Hayat Onyüksel; Prem S Mohanty; Israel Rubinstein
Journal: Int J Pharm Date: 2008-08-27 Impact factor: 5.875

Review 3. Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.

Authors: Darren Lars Stirland; Joseph W Nichols; Seiji Miura; You Han Bae
Journal: J Control Release Date: 2013-10-02 Impact factor: 9.776

4. An optical and microPET assessment of thermally-sensitive liposome biodistribution in the Met-1 tumor model: Importance of formulation.

Authors: E E Paoli; D E Kruse; J W Seo; H Zhang; A Kheirolomoom; K D Watson; P Chiu; H Stahlberg; K W Ferrara
Journal: J Control Release Date: 2009-12-16 Impact factor: 9.776

Review 5. Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.

Authors: Alberto Gabizon; Hilary Shmeeda; Yechezkel Barenholz
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

6. Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: a novel therapeutic approach for breast cancer and breast cancer stem cells.

Authors: Ece Gülçür; Mentor Thaqi; Fatima Khaja; Antonina Kuzmis; Hayat Önyüksel
Journal: Drug Deliv Transl Res Date: 2013-12 Impact factor: 4.617

Review 7. Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma.

Authors: Miriam Sharpe; Stephanie E Easthope; Gillian M Keating; Harriet M Lamb
Journal: Drugs Date: 2002 Impact factor: 9.546

Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl).